This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,788.48, is for the supply of APREPITANT 40 MG CAPSULE UD 5S, a type of prescription medication. The contract has a firm fixed price pricing type and a completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $7,008.15, with a Firm Fixed Price pricing type. The award is for the provision of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract has an Ultimate Completion Date of June 12, 2025. Amerisourcebergen Drug Corp is the prime contractor on this award, which is...
This federal contract award, valued at $4,162.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product, with a performance period extending through April 2025. The contract is a delivery order and is priced on a firm-fixed-price basis. It is not designated as a set-aside contract, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The contract, awarded by the Defense Logistics Agency (DLA), is for the provision of 4564445711 - APREPITANT 40 MG CAPSULE UD 5S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $3,954.22 and has an ultimate completion date of May 1, 2024. This...
This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6PDN, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,186.78 firm fixed-price Delivery Order is for the supply of 4564978529 APREPITANT 80 MG CAPSULE UD 6S. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
This federal contract award was issued by the Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,368.44 firm fixed price delivery order is for the supply of 40 mg Aprepitant capsules, which are a specialty pharmaceutical product used in medical treatment programs and facilities. AmerisourceBergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Aprepitant 80 mg capsules. The $3,354.88 firm fixed price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The...
This federal contract award was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract, valued at up to $18,539.00, is a Delivery Order for the supply of Aprepitant 80 mg capsules. The contract has a period of performance ending on April 23, 2024 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,264.84, is for the delivery of 36,000 unit capsules of a pharmaceutical product over a period ending on July 14, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, valued at $10,337.73, to provide 4,568,121,027 units of a 24,000 unit capsule medication with an ultimate completion date of May 5, 2025. The contract is not designated as a set-aside and was awarded on May 2, 2025. Amerisourcebergen Drug Corp...